Xiran He
Beijing, 101125, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3Kγ inhibitor can enhance immunogenicity and eradicate tumors.
Journal: Journal for immunotherapy of cancer
Published: January 25, 2022
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib.
Journal: Translational oncology
Published: June 17, 2021
Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma.
Journal: Journal for immunotherapy of cancer
Published: September 29, 2020
Rare case of apatinib acquired resistance induced by point mutation of WRN p.V697F through activation of the PI3K/AKT apoptosis-inhibiting pathway.
Journal: Thoracic cancer
Published: September 15, 2020
Exercise on quality of life and cancer-related fatigue for lymphoma survivors: a systematic review and meta-analysis.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 24, 2019
Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Journal: International journal of oncology
Published: January 09, 2017
Antitumor effects of Xi Huang pills on MDA‑MB‑231 cells in vitro and in vivo.
Journal: Molecular medicine reports
Published: February 14, 2016
Meta-analysis on treatment of non-small cell lung cancer with brucea javanica oil emulsion in combination with platinum-contained first-line chemotherapy
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: October 02, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026